Medical News

RSS

Shrink Nanotechnologies files patent applications for CellAlign advanced tissue engineering technology

Shrink Nanotechnologies, Inc., an innovative nanotechnology company developing products and licensing opportunities in the solar energy production, medical diagnostics and sensors and biotechnology research and development tools businesses, announced today that certain patent applications related to its advanced tissue engineering technology platform, CellAlign™, have been filed.

15 Jul 2010

Practice Fusion API Challenge kicked off

Practice Fusion, the free, web-based Electronic Health Record company, kicked off the Practice Fusion API Challenge today as part of the Health 2.0 Developer Challenge, an initiative supported by the US Department of Health and Human Services. The challenge invites developers to connect patient health data from medical devices, mobile apps, social media systems and websites to doctors in real-time through Practice Fusion's new API.

15 Jul 2010

Justice for exposure to asbestos

A leading industrial illness lawyer has won justice for the family of a man who died after being exposed to asbestos whilst working at the Sellafield nuclear plant.

15 Jul 2010

National Jewish Health named #1 respiratory hospital in the nation

For the 13th consecutive year, National Jewish Health has been named the #1 respiratory hospital in the nation by U.S. News & World Report.

15 Jul 2010

Access announces agreement to develop oral formulation of proprietary injectable drugs

Access Pharmaceuticals, Inc., announced today that it has entered into a pre-licensing feasibility agreement with a leading biotechnology company to develop an oral formulation of its currently-marketed, proprietary injectable drugs. Access will utilize its proprietary Cobalamin Oral Drug Delivery Technology to develop oral formulations of the drug for pre-clinical testing.

15 Jul 2010

Ligand Pharmaceuticals announces launch of redesigned Web site

Ligand Pharmaceuticals Incorporated announces the launch of its completely redesigned Web site: www.ligand.com. The new Web site is designed as a comprehensive resource for investors, prospective corporate partners and the life science community to learn more about Ligand's business model, robust pipeline, high-profile partnerships and innovative technology.

15 Jul 2010

NovaBay Pharmaceuticals issued Notice of Allowance for broad portfolio of anti-infective compounds

NovaBay Pharmaceuticals, Inc. announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office on a patent application for a broad portfolio of anti-infective compounds, including NVC-612. The patent will broaden protection for NovaBay's first-in-class Aganocide family of compounds, which are designed to fight infections without causing drug resistance.

15 Jul 2010

AHCA recognizes Advocat's long term care facilities with 2010 National Quality Awards

Advocat Inc. today announced that five of its long term care facilities were recognized with 2010 National Quality Awards by the American Healthcare Association (AHCA).

15 Jul 2010

Sharp HealthCare deploys Allscripts Community Record for all employed physicians

Allscripts today announced that Sharp HealthCare has selected the Allscripts Community Record, provided in partnership with dbMotion, to deliver end-to-end connectivity across the health system. Using the Allscripts solution, Sharp's caregivers and those in affiliated physician practices will have shared access to a single, unified patient record, bridging gaps that often exist between hospital-based and office-based care.

15 Jul 2010

Cryo-Cell second-quarter consolidated revenues decrease to $4.3 million

Cryo-Cell International, Inc., one of the world's largest and most established family cord blood banks, today announced results for the second quarter ended May 31, 2010. Consolidated revenues for the second quarter of fiscal 2010 were $4.3 million compared to $4.7 million for the second quarter of fiscal 2009.

15 Jul 2010

Nitto Denko, Quark collaborate to develop siRNA therapeutics for fibrotic diseases

Nitto Denko Corporation, Japan's leading diversified materials manufacturer and Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, today announced the initiation of a collaboration and license agreement for the development of siRNA therapeutics for the treatment of fibrotic diseases.

15 Jul 2010

Smokers exposed to wood smoke are at increased risk of COPD: Research

Smokers who are exposed to wood smoke, either through home heating and cooking or through ambient neighborhood pollution, are not only at increased risk of COPD, but are also more likely to have epigenetic changes in the DNA that further increase their risk of COPD and related pulmonary problems.

15 Jul 2010

Sepracor to change name to Sunovion Pharmaceuticals

Sepracor Inc. and Dainippon Sumitomo Pharma Co., Ltd., an Osaka, Japan-based pharmaceutical company, announced today the intent to change the Sepracor name to Sunovion Pharmaceuticals Inc. in the United States. DSP acquired Sepracor in October 2009 and the name change is planned to occur in anticipation of the one-year anniversary of the acquisition. Sepracor intends to begin officially operating as Sunovion Pharmaceuticals Inc. before the end of 2010.

15 Jul 2010

Premier, Xoft execute group purchasing contract

Premier Inc., an alliance of more than 2,300 U.S. hospitals and 67,000-plus other healthcare sites working together to achieve high quality, cost-effective care, and Xoft, Inc., the leading provider of FDA-cleared Electronic Brachytherapy Systems, announced the execution of a group purchasing contract. Xoft was awarded an exclusive three-year contract for brachytherapy systems with Premier Purchasing Partners L.P., the group purchasing unit of Premier, Inc.

15 Jul 2010

Endo acquires HealthTronics

Endo Pharmaceuticals announced today the completion of its acquisition of HealthTronics, Inc., a leading U.S. provider of urological products and services, located in Austin, Texas.

15 Jul 2010

Type 1 diabetes affects athletic performance, new study finds

A new study led by York University researchers finds that young athletes with Type 1 diabetes may experience a marked decrease in performance as a result of their blood sugar levels.

15 Jul 2010

Fatness drives inactivity, not the other way around

According to a recent longitudinal study in children, inactivity does not lead to fatness! Moreover, the authors concluded that fatness is driving inactivity, and not the other way around. The authors noted that this "reverse causality" explains the observed association between inactivity and fatness. It also explains the repeated failures of the attempts to reduce childhood obesity by increasing physical activity. The study was published in the Archives of Disease in Childhood by Dr. Brad Metcalf and colleagues from Plymouth, UK.

15 Jul 2010

ALLOZYNE signs worldwide licensing agreement with The Scripps Research Institute

ALLOZYNE Inc. announced today the signing of a worldwide licensing agreement with The Scripps Research Institute. The agreement gives ALLOZYNE rights to a unique and powerful chemical reaction, developed by Nobel Laureate K. Barry Sharpless of Scripps Research, known as "Click chemistry." The novelty of this reaction comes from its ability to introduce two different molecular components and have them "click" together stably and irreversibly.

15 Jul 2010

Adolescents with good physical condition experience better appetite control, energy expenditure: Study

Adolescents of ages between 12 and 17, with a good physical condition and regular physical activity present increased levels of insulin and leptin, which are hormones involved in the development of diabetes, appetite control and energy expenditure. This was the conclusion drawn from a study recently conducted at the Department of Physiology of the University of Granada. Further, after thorough analysis of a number of scientific studies, they also concluded that physical activity and physical condition are negatively associated to adolescents' body fat.

15 Jul 2010

Top treatments and tests for hair loss

August is National Hair Loss Awareness Month and it's an important time for men and women to talk to their doctors about the newest tests and treatments available to help them. Over 100 million Americans are affected - including 60 million men and 40 million women.

15 Jul 2010

Medical News

Shrink Nanotechnologies files patent applications for CellAlign advanced tissue engineering technology

Practice Fusion API Challenge kicked off

Justice for exposure to asbestos

National Jewish Health named #1 respiratory hospital in the nation

Access announces agreement to develop oral formulation of proprietary injectable drugs

Ligand Pharmaceuticals announces launch of redesigned Web site

NovaBay Pharmaceuticals issued Notice of Allowance for broad portfolio of anti-infective compounds

AHCA recognizes Advocat's long term care facilities with 2010 National Quality Awards

Sharp HealthCare deploys Allscripts Community Record for all employed physicians

Cryo-Cell second-quarter consolidated revenues decrease to $4.3 million

Nitto Denko, Quark collaborate to develop siRNA therapeutics for fibrotic diseases

Smokers exposed to wood smoke are at increased risk of COPD: Research

Sepracor to change name to Sunovion Pharmaceuticals

Premier, Xoft execute group purchasing contract

Endo acquires HealthTronics

Type 1 diabetes affects athletic performance, new study finds

Fatness drives inactivity, not the other way around

ALLOZYNE signs worldwide licensing agreement with The Scripps Research Institute

Adolescents with good physical condition experience better appetite control, energy expenditure: Study

Top treatments and tests for hair loss

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News